Maoyuan Zhao

1.4k total citations
64 papers, 772 citations indexed

About

Maoyuan Zhao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Maoyuan Zhao has authored 64 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Maoyuan Zhao's work include Cancer-related molecular mechanisms research (9 papers), Cancer Cells and Metastasis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Maoyuan Zhao is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Cancer Cells and Metastasis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Maoyuan Zhao collaborates with scholars based in China, United States and Germany. Maoyuan Zhao's co-authors include Zimin Wei, Jinhao Zeng, Yue Zhao, Nianzhi Chen, Wenhao Liao, Hongyang Cui, Shubo Zhang, Yuyi Wang, Feng Luo and Qiao Zheng and has published in prestigious journals such as The Science of The Total Environment, Journal of Hazardous Materials and Bioresource Technology.

In The Last Decade

Maoyuan Zhao

59 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maoyuan Zhao China 16 297 124 119 115 110 64 772
Yanyan Zhu China 16 393 1.3× 29 0.2× 60 0.5× 68 0.6× 106 1.0× 41 856
Bowen Yang China 15 478 1.6× 29 0.2× 182 1.5× 251 2.2× 81 0.7× 29 1.1k
Sandip Mukherjee India 18 296 1.0× 56 0.5× 23 0.2× 91 0.8× 97 0.9× 30 1.0k
Zhaowei Yan China 14 268 0.9× 52 0.4× 61 0.5× 52 0.5× 23 0.2× 45 579
Dongmei Fan China 17 214 0.7× 51 0.4× 49 0.4× 69 0.6× 23 0.2× 48 713
Hong Xiang China 20 310 1.0× 22 0.2× 70 0.6× 226 2.0× 24 0.2× 44 994
Hanrui Chen China 13 173 0.6× 12 0.1× 52 0.4× 81 0.7× 134 1.2× 38 518
Haifei Chen China 20 260 0.9× 29 0.2× 81 0.7× 80 0.7× 189 1.7× 67 1.0k
Jiao China 12 261 0.9× 46 0.4× 26 0.2× 92 0.8× 29 0.3× 119 645
Jiajia Cui China 18 262 0.9× 19 0.2× 97 0.8× 69 0.6× 52 0.5× 42 732

Countries citing papers authored by Maoyuan Zhao

Since Specialization
Citations

This map shows the geographic impact of Maoyuan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maoyuan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maoyuan Zhao more than expected).

Fields of papers citing papers by Maoyuan Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maoyuan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maoyuan Zhao. The network helps show where Maoyuan Zhao may publish in the future.

Co-authorship network of co-authors of Maoyuan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Maoyuan Zhao. A scholar is included among the top collaborators of Maoyuan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maoyuan Zhao. Maoyuan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Xiangyu, et al.. (2025). Disruption of intestinal barrier and dysbiosis of gut microbiota in an experimental rhesus macaque model with 6-year diabetes mellitus. EXPERIMENTAL ANIMALS. 74(4). 384–398. 1 indexed citations
2.
Chen, Nianzhi, Maoyuan Zhao, Zexu Gu, et al.. (2025). Dehydrodiisoeugenol targets NOD2 exerting dual effects against colitis and colorectal cancer: a double-edged sword. Molecular Medicine. 31(1). 221–221.
3.
Wang, Mingyu, Genxu Wang, Maoyuan Zhao, et al.. (2025). Jujuboside A in ameliorating insomnia in mice via GABAergic modulation of the PVT. Journal of Ethnopharmacology. 349. 119939–119939.
4.
Zhao, Maoyuan, Yi Yang, Huafeng Pan, et al.. (2024). (-)-Asarinin alleviates gastric precancerous lesions by promoting mitochondrial ROS accumulation and inhibiting the STAT3 signaling pathway. Phytomedicine. 126. 155348–155348. 8 indexed citations
5.
Zhao, Maoyuan, Dan Pu, Zhixi Li, et al.. (2024). Impact of Pulmonary microbiota on lung cancer treatment-related pneumonia. Journal of Cancer. 15(14). 4503–4512. 4 indexed citations
6.
Zhao, Maoyuan, et al.. (2024). Global research trends on the associations between the microbiota and lung cancer: a visualization bibliometric analysis (2008–2023). Frontiers in Microbiology. 15. 1416385–1416385. 1 indexed citations
7.
Chen, Hongqing, Wen Tian, Wenhao Liao, et al.. (2023). AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling. Stem Cells International. 2023. 1–21. 10 indexed citations
8.
Zhang, Lanlan, Maoyuan Zhao, Wenhao Liao, et al.. (2023). Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Phytotherapy Research. 37(5). 2036–2050. 16 indexed citations
9.
10.
Liang, Dan, Lu Liu, Maoyuan Zhao, et al.. (2023). Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway. International Immunopharmacology. 124(Pt A). 110902–110902. 11 indexed citations
11.
Pan, Huafeng, Maoyuan Zhao, Jundong Wang, et al.. (2023). Natural products for gastric carcinoma prevention and treatment: Focus on their antioxidant stress actions in the Correa's cascade. Phytomedicine. 123. 155253–155253. 9 indexed citations
12.
Zhao, Ziyi, Xiaomei Zhang, Yanlei Guo, et al.. (2022). Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy. Phytotherapy Research. 36(9). 3371–3393. 14 indexed citations
13.
Zhao, Maoyuan, et al.. (2022). Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review. Inflammopharmacology. 30(6). 2035–2050. 24 indexed citations
14.
Yuan, Meng, Yirui Zhai, Yu Men, et al.. (2022). Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer. Thoracic Cancer. 13(23). 3331–3340. 6 indexed citations
15.
Zeng, Jinhao, Xiao Ma, Yu Chen, et al.. (2021). Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction. Frontiers in Pharmacology. 12. 682713–682713. 19 indexed citations
16.
Cui, Hongyang, Shubo Zhang, Maoyuan Zhao, Yue Zhao, & Zimin Wei. (2019). Parallel faction analysis combined with two-dimensional correlation spectroscopy reveal the characteristics of mercury-composting-derived dissolved organic matter interactions. Journal of Hazardous Materials. 384. 121395–121395. 73 indexed citations
17.
Wu, Wenchao, et al.. (2017). HIF-1α mediates visfatin-induced CTGF expression in vascular endothelial cells. Cellular and Molecular Biology. 63(4). 28–28. 5 indexed citations
18.
Zhang, Nan, Yanyang Liu, Yuyi Wang, et al.. (2017). Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. Drug Design Development and Therapy. Volume11. 969–983. 42 indexed citations
19.
Wang, Yuyi, Ming Jiang, Zhixi Li, et al.. (2015). Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors. Cell & Bioscience. 5(1). 72–72. 14 indexed citations
20.
Zhao, Maoyuan, Fangcheng Fu, M. Huang, et al.. (2014). Investigation of equation of state and in-mediumNNcross sections through nuclear stopping. Physical Review C. 89(3). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanyan Zhu Breakdown of academic impact, for papers by Bowen Yang Breakdown of academic impact, for papers by Sandip Mukherjee Breakdown of academic impact, for papers by Zhaowei Yan Breakdown of academic impact, for papers by Dongmei Fan Breakdown of academic impact, for papers by Hong Xiang Breakdown of academic impact, for papers by Hanrui Chen Breakdown of academic impact, for papers by Haifei Chen Breakdown of academic impact, for papers by Jiao Breakdown of academic impact, for papers by Jiajia Cui
Rankless by CCL
2026